⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2399581 | 1.00 | — | — | |
| SCHEMBL13363704 | 1.00 | — | — | |
| SCHEMBL18629182 | 1.00 | — | — | |
| Methylamine SCHEMBL27737021 | 0.98 | KDM1A (0.40) | — | |
| SCHEMBL2898745 | 0.84 | — | — | |
| SCHEMBL17780158 | 0.84 | — | — | |
| SCHEMBL17780168 | 0.84 | — | — | |
| SCHEMBL25803801 | 0.84 | — | — | |
| SCHEMBL22011091 | 0.82 | ALDH1A1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL29512178 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303489-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2023-09-28 | — | — | US | disclosed |
| US-11542233-B2 | Compounds, compositions and methods of use | AQUINNAH PHARMACEUTICALS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-11117887-B2 | Aryl substituted pyrimidines for use in influenza virus infection | Janssen Sciences Ireland Unlimited Company (IE) | 2021-09-14 | — | — | US | disclosed |
| US-20200270211-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2020-08-27 | — | — | US | disclosed |
| US-20200231577-A1 | ARYL SUBSTITUTED PYRIMIDINES FOR USE INFLUENZA VIRUS INFECTION | Janssen Sciences Ireland Unlimited Company (IE) | 2020-07-23 | — | — | US | disclosed |
| US-10611755-B2 | Aryl substituted pyrimidines for use in influenza virus infection | JANSSEN SCIENCES IRELAND UC (IE) | 2020-04-07 | — | — | US | disclosed |
| US-20190047989-A1 | ARYL SUBSTITUTED PYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION | Janssen Sciences Ireland Unlimited Company (IE) | 2019-02-14 | — | — | US | disclosed |
| EP-3141252-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | Vertex Pharmaceuticals Inc. (US) | 2017-03-15 | — | — | EP | disclosed |